Pneumovax

Pneumovax is the pneumococcal polysaccharide vaccine, which protects against severe pneumonia infections caused by the bacterium Streptococcus pneumoniae. This bacterium often leads to pneumonia and meningitis in children, older adults, and people with chronic illnesses. The vaccine was developed by Michael Heidelberger (1888-1991 ) and first used on American servicemen in World War Ⅱ.

 

대부분의 사람들에게 백신은 한차례만 접종되어지면 된다. 비록 어떤 사람들은 두번이 필요하기도 하지만 말이다. 백신은 2살 이상의 심장질환, 폐질환(천식을 포함해서), 신장질환, 알콜중독자, 당뇨병, 경화증, 뇌척수액이 새거나 겸상 적혈구성 빈혈을 가진 고위험군의 환자들에게 추천되어진다. 혹은 65세 이상의 만성적인 건강 문제를 갖고 있거나, 약해진 면역 체계를 갖고 있는 사람들과 같은 시설에서 생활하는 사람들, 알래스카 토착민들, 몇몇 아메리칸 인디언들도 위험할 수 있다.

 

The risks and side effects associated with the pneumococcal vaccine are usually minor. You might experience pain and redness at the site of the injection. And, like all medications, Pneumovax carries a small chance of an allergic reaction, a more serious reaction, or even death. If you are sick or possibly pregnant, you should let your doctor know before receiving the vaccine; he or she may opt to postpone the inoculation.

 

비록 당신이 폐렴이나 다른 침습성 폐렴 구균성 질환을 과거에 갖고 있었다 해도 당신이 모든 타입의 폐렴구균성 감염에 면역력이 있는 건 아니므로 만약 권장되어진다면 여전히 백신을 맞아야 한다. 그러나 Pneumovax 가 모든 종류의 폐렴을 다 예방하지는 않는다.

 

 

 

Pneumovax does not protect against pneumococcal diseases in children under age 2. Another vaccine, called the pneumococcal conjugate vaccine, is routninely given to children under 2 to protect against Streptococcus pneumoniae.

 

Before vaccines that protect against pneumococcal disease existed in the United States, 200 deaths in children younger than age 5 used to occur annually as a result of these illnesses.

 

There are more than 90 subtypes of Streptococcus pneumoniae bacteria. The 10 most common subtypes cause 62 percent of invasive disease worldwide.

 

Approximately 175,000 hospitalization resulting from pneumococcal pneumonia occur annually in the United States, and 5 to 7 percent of those patients will die.